drugset / Trial / NCT00185185
Olmesartan Medoxomil in Atherosclerosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study in hypertensive patients with atherosclerosis and increased cardiovascular risk. The efficacy of olmesartan medoxomil on atherosclerosis is measured.
Timeline
- Start
- 2001-11
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atenolol | Other / unclassified | — | — |
| Subject | Olmesartan medoxomil | Unknown | — | — |
| Background | Hydrochlorothiazide | Unknown | — | — |